Vanderbilt & Qsource Webinar Series

Similar documents
Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit

9/11/2012. Clare I. Hays, MD, CMD

Psychotropic Medication. Including Role of Gradual Dose Reductions

Reducing Antipsychotic Drug Use in Long Term Care

How to use the CMS Hand in Hand Training for Dementia Care

Integrating INTERACT into Interim Pharmacist Reviews

Management of Behavioral Symptoms in Dementia. Brenda Jordan, MS, ARNP, BC- PCM Dartmouth-Hitchcock Kendal

OBJECTIVES. Achieving Success in Reducing Inappropriate Use of Antipsychotic Medication in Patients with Dementia

Re: Medicare and Medicaid Programs; Reform of Requirements for Long-Term Care Facilities

12/17/2012. Unnecessary Drugs

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care

New England QIN-QIO Reducing Unnecessary Antipsychotic Medications Affinity Group Call Thursday, January 19 th 3-4:00 pm. Presenters.

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

Behavioural and Psychological Symptoms and Medications Presentation

Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use

Risks of Antipsychotics use In Dementia

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia

Vanderbilt & atom Alliance Webinar Series

Drugs used to relieve behavioural and psychological symptoms in dementia

Antipsychotic Medications

Behavior Problems: in Long Term Care and Assisted Living

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP

QAPI Relay Residents Who Self-Report Moderate to Severe Pain Long-Stay Quality Measure Coding Improvements

Sleep Better. Program Workbook

Recognition and Management of Behavioral Disturbances in Dementia

THE BEHAVIOURAL VITAL SIGNS (BVS) TOOL

CEPP National Audit Antipsychotics in Dementia

Dementia Support Across the Care Continuum

Improving Dementia Care in Nursing Homes Through Best Care Practices

PSYCHOTROPIC SOLUTIONS

Management of Behavioral Problems in Dementia

Improving the quality of care of patients with delirium

Northumbria Healthcare NHS Foundation Trust. Your guide to understanding Delirium. Issued by Department of Medicine

Wicking Dementia Research & Education Centre, University of Tasmania, 2017

PSYCHOTROPIC MEDICATIONS IN LTC CHALLENGES AND OPPORTUNITIES FOR BEST PRACTICES

PSYCHOTROPIC SOLUTIONS

Dementia: Reducing use of antipsychotics in patients with behavioural and psychological symptoms of dementia (BPSD) National & London Context

DRAFT. Consultees are asked to consider and comment on the CEPP National Audit: Antipsychotics in Dementia document.

Introduction to Dementia: Complications

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD

KINGSTON DEMENTIA RATING SCALE

Dementia Training Session for Carers. By Dr Rahul Tomar Consultant Psychiatrist

The place for treatments of associated neuropsychiatric and other symptoms

Non-pharmacological Approaches in Dementia Care. Dr. Anna Fisher

Dementia Care Principles

N.C. Nurse Aide I Curriculum MODULE T. Dementia and Alzheimer s Disease. DHSR/HCPR/CARE NAT I Curriculum - July

Delirium. Quick reference guide. Issue date: July Diagnosis, prevention and management

Dementia ALI ABBAS ASGHAR-ALI, MD STAFF PSYCHIATRIST MICHAEL E. DEBAKEY VA MEDICAL CENTER ASSOCIATE PROFESSOR BAYLOR COLLEGE OF MEDICINE

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Psychosocial Outcome Severity Guide Instructor s Guide

Non-Pharmacological Interventions for Persons With Dementia. John Erpenbach, CNP Michele Snyders, LCSW, ACHP-SW

GERIATRIC ADULT MENTAL HEALTH SPECIALTY TEAM TRAINING MODULES

Palliative Care for People Living with Dementia: Why Comfort Matters. Learning Objectives. Participants will: The Beatitudes Campus Story

October 28, Geriatrics Update Course. Lesley Wiesenfeld, MD, MHCM, FRCPC. Managing BPSD. Geriatric Psychiatrist, Mount Sinai Hospital

Managing Behavioral Issues

5/17/2017. Conflicts of Interest. Key Takeaways

Dementia Information Kit for HACC Workers

Decreasing Delirium Resolution Times for the Elderly: An Interprofessional Approach

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia

Patient and Family Engagement Campaign; Dementia Friendly Hospital Initiative

Workshop 5: Mapping A QAPI Journey around Falls Dr. Anna Fisher / Barb Sisarcick / Claire Enright

We know you will have questions

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

Telepsychiatry In Rural Nursing Homes

Lori Hintz, RN Quality Improvement Advisor Great Plains Quality Innovation Network SD Foundation for Medical Care

Session outline. Introduction to dementia Assessment of dementia Management of dementia Follow-up Review

Delirium Information for patients and relatives. Delirium is common Delirium is treatable Relatives can stay to help us

Parkinsonian Disorders with Dementia

Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease

Working Together to Enhance Understanding of Responsive Behaviours in Long-Term Care

Clear Webinar Series: Person Centered Approach & Recreation Therapy. May 24, 2018

Managing Challenging Behaviors

Delirium Prevention: The State-of-the-Art & Implications to Improve Care in our State

Palliative Care Consult Service

Multi-morbidity in Dementia: A 21st Century Challenge. Sube Banerjee. Professor of Dementia Brighton and Sussex Medical School

Across the Spectrum of Dementia. Keys to Understanding Behaviours & Anticipating Needs

Confused Hospitalised Older Persons Program CHOPS. 26 th March 2015 HNE Falls Forum

Addressing Difficult Behaviors in Dementia

Home Health (2-Hour) Online Dementia Care Training Program

Deidre Pye MClinPsych Senior Behaviour Consultant Dementia Behaviour Management Advisory Service (Qld)

American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline

Dementia & Delirium: Contents. Behaviours, Symptoms & Integrated Person-Centred Care. You & Your Care Dementia Pg.

Neuropsychiatric Inventory Nursing Home Version (NPI-NH)

Beyond the Bath: Leading Dementia Care in Long Term Care

Dementia in Long Term Care: How Dementia Affects Care Planning

Supporting people with dementia to live well in London care homes

nicheprogram.org 16th Annual NICHE Conference Forging New Paths and Partnerships 1

Assessment and management of behavioral and psychological symptoms of dementia

Behavioral and Psychological Symptoms of dementia (BPSD)

Talking to Patients and Their Families

How Aging and Dementia Effect Resident Behaviors

BEHAVIORAL PROBLEMS IN DEMENTIA

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA

We Will Discuss. Dementia and Alzheimer s Disease Basics. Dementia. Developmental Disabilities and Dementia: A Behavior Management Guide

Senior Moments or Something More? Copyright James L. West Alzheimer s Center, 2013 All Rights Reserved

Summary of funded Dementia Research Projects

Delirium. Delirium is characterized by an acute onset (hours or days) and fluctuating course of deterioration in mental functioning.

Transcription:

Vanderbilt & Qsource Webinar Series

Vanderbilt Medical Center Vanderbilt University Center for Quality Aging Qsource

Session #1: Introduction to Dementia Care & QAPI Session #2: Dementia & Behavioral Disturbances Session #3: Psychopharmacology in the Nursing Home Session #4: Principles of Non-pharmacologic Management & the Formulation of Behavioral Care Plans Session #5: The Implementation of Behavioral Strategies & the Management of Pharmacologic Interventions Session #6: Addressing Barriers to Change: the Perspective of Psychiatry, Nursing, and Medical Directors

Chat Monitor: Britt Kuertz, RDN Brittany.t.kuertz@vanderbilt.edu 615-936-1499 Moderator: Emily Hollingsworth, MSW Emily.k.hollingsworth@vanderbilt.edu 615-936-2718

How many people are in the room with you to view this webinar? (Please answer in the chat pane, and be sure to include your full facility name)

How would you describe your facility s current efforts to reduce antipsychotic medication use? A. We just recently started focusing on this topic and are trying to learn more. B. We ve been actively trying to reduce antipsychotic medications but have experienced challenges and need further guidance. C. We have successfully reduced antipsychotic medications but there is still room for more improvement.

Presenters: Beth Hercher, CPHQ, Qsource Carrie Plummer, PhD, ANP-BC, Vanderbilt School of Nursing James Powers, MD, Vanderbilt University Medical Center

James Powers, MD Carrie Plummer, PhD, ANP-BC Beth Hercher, CPHQ

1. To provide an overview of dementia and problem behaviors in nursing homes. 2. To describe the potential adverse effects of antipsychotic medications for managing problem behaviors. 3. To provide an introduction to QAPI and its application to reduce antipsychotic medications.

Of Medicare beneficiaries residing in Nursing Homes, 64% have Alzheimer s Disease (AD) or other dementias. 78% of nursing home residents with dementia exhibit behavioral and psychological symptoms of dementia (BPSD). 41% of residents with BPSD exhibit symptoms of psychosis. https://www.alz.org/downloads/facts_figures_2014.pdf

Caring for a person with dementia requires an average of 197 more care hours per year than caring for someone without dementia. This number increases as the severity of cognitive impairment increases.

Wandering Sleep Disturbances Sexual Inappropriateness Verbal Agitation: Abnormal/Repetitive Vocalizations Physical Agitation: Repetitive Motor Activity Verbal and/ or Physical Aggression Crying Psychosis (delusions and/or hallucinations)

Centers for Medicare and Medicaid Services (CMS) Initiative released in April 2012. Office of Inspector General (OIG) reportoveruse of antipsychotics in nursing homes. Antipsychotic use factors into CMS- issued Star Rating.

CMS has developed a national partnership to improve the quality of care provided to individuals with dementia living in nursing homes This partnership is focused on delivering health care that is person-centered, comprehensive, and interdisciplinary. Reduce use of unnecessary antipsychotic medications

The average percentage of long-stay residents on antipsychotics: 18.7% in reporting nursing homes in the Unites States (CMS, 2015 Q1) 21.6% in Tennessee (CMS, 2015 Q1) CMS goal is to reduce antipsychotic use to 15% nationally (or 17% for Tennessee)

Associated Adverse Effects: Sedation Confusion/ Cognitive Worsening Worsening Psychotic Symptoms Restlessness/ Movement Disorders Slowness of Gait Increased Fall Risk Weight Gain Increased Blood Sugar

When antipsychotics are necessary how do we appropriately document this necessity? CMS guidelines: Must present a danger to the person with dementia or others, or cause the person with dementia to experience one of the following: Inconsolable or persistent distress, A significant decline in function, or Substantial difficulty receiving needed care.

How do we institute improvements at our facility?

The Model for Improvement What are we trying to accomplish? Aim How will we know that a change is an improvement? Measure What changes can we make that will result in improvement? Change

Specific Measurable Attainable Relevant Time-bound Example Aim: To reduce the percentage of residents receiving routine antipsychotics to manage problem behaviors by 10% in the next six months.

Determine which data to monitor routinely Set targets for performance in the areas you are monitoring Identify benchmarks for performance Develop a data collection plan, including: who will collect which data? who will review it? how frequently will it be collected and reported? Download resource at http://www.qsource.org/12-action-steps-qapi/

Provide a Baseline Identify areas needing further investigations Identify areas needing improvement Evaluate impact of new changes or programs Effectiveness of quality improvement program Balancing measures (unexpected changes of program) Determine which changes resulted in improvements

How do you know the changes will produce the desired outcomes? Root Cause Analysis (RCA) Plan, do, study, act (PDSA) cycles

Helps identify the primary cause(s) of a problem to determine what happened determine why it happened determine what to do to reduce the likelihood of it happening again Tools: RCA Five Whys Worksheet Fishbone Diagram

Identify event to be investigated and what questions to ask Establish leadership team to review Describe what happened Identified the contributing factors Identify root causes http://www.cms.gov/medicare/provider-enrollment-and- Certification/QAPI/downloads/qapifiveelements.pdf

What are we trying to accomplish? In the next six months, our facility will reduce the number of residents with dementia who are receiving routine antipsychotics to manage problem behaviors. Think SMART: S Specific M Measurable A Attainable R Relevant T Time-bound

How will we know that a change is an improvement? We will track the incidence of antipsychotic use among high-risk residents by conducting weekly behavioral assessments

What changes can we make that will lead to improvement? We will document and implement nonpharmacological interventions for residents with behavioral disturbance

Monitor and modify effectiveness Changes that result in improvement Learning Hunches, theories, ideas e.g., action plans or interventions

QAPI is a new regulatory requirement facilities must adopt to avoid penalties A. True B. False

Full video available on project website: www.vanderbiltantipsychoticreduction.org

Retired army colonel with dementia Hospitalized with UTI Structured geriatric ward Family meeting on goals of care

Medications for agitation should be a last resort after failing non-pharmacologic management Low-dose medications with continued efforts to reduce and eliminate psychotropics Avoid p.r.n. s

Patient-centered goals of care should be developed with the resident and family Medications for agitation should be a last resort Non-pharmacologic management techniques include Normalize day and night schedules Re-orient, re-direct Anticipate resident needs

Antipsychotic medication should be used only after non-pharmacological treatment has been attempted. A. True B. False

Antipsychotic medications are commonly used to manage problem behaviors (21.6% in TN) There are numerous potential adverse effects of these medications (e.g., sedation, confusion, falls) The QAPI framework can be used to safely and appropriately reduce the use of these medications There will be a second presentation of Session #1 on Tuesday, October 27 th at 1pm CST/ 2pm EST

Two options for attending Session 2: November 3rd (Tuesday) 1pm CST/ 2pm EST November 18th (Wednesday) 10am CST/ 11am EST

Emily Hollingsworth Emily.K.Hollingsworth@vanderbilt.edu Britt Kuertz Brittany.T.Kuertz@vanderbilt.edu Project Website: www.vanderbiltantipsychoticreduction.org Vanderbilt Center for Quality Aging 615-936-1499 www.vanderbiltcqa.org for other resources